Empagliflozin-25mg & linagliptin-5mg (Empashield-L)25/5
Empagliflozin 25mg & Linagliptin 5mg Tablets (Empashield-L 25/5) offer a dual-action solution for managing Type 2 diabetes. This combination works by removing excess glucose through urine and improving insulin function. It helps maintain stable blood sugar levels, reduces complications, and enhances patient convenience with once-daily dosing. Ideal for patients needing combination therapy, it supports better diabetes control alongside lifestyle changes. Manufactured with high-quality standards, Empashield-L ensures effective and reliable treatment.
Description
Empagliflozin 25mg & Linagliptin 5mg Tablets provide an advanced dual-action therapy designed to manage Type 2 diabetes effectively. This powerful combination, marketed as Empashield-L 25/5, works by reducing blood sugar levels through two complementary mechanisms. Empagliflozin helps eliminate excess glucose through urine, while Linagliptin enhances insulin secretion and reduces glucose production in the liver.
This medication supports consistent glycemic control and lowers the risk of diabetes-related complications. Doctors often prescribe it when single-drug therapy does not achieve desired results. Patients benefit from improved blood sugar regulation, better metabolic function, and enhanced overall health outcomes.
Empashield-L 25/5 offers convenience with once-daily dosing, making it easier for patients to stay consistent with their treatment plan. Its dual formulation reduces the need for multiple medications, improving adherence and simplifying diabetes management.
Manufactured under strict quality standards, this medicine ensures safety, reliability, and effectiveness. It is suitable for adults with Type 2 diabetes who require combination therapy alongside diet and exercise.
Manufactured with strict pharmaceutical standards, Empashield-L 25/5 guarantees quality, safety, and consistent performance. Healthcare professionals recommend this medication as part of a comprehensive diabetes management plan that includes a balanced diet, regular exercise, and routine monitoring of blood glucose levels.
Patients using Empagliflozin 25mg & Linagliptin 5mg Tablets should follow their doctor’s advice carefully to achieve optimal results. Regular monitoring helps ensure effectiveness and minimizes potential side effects. This medication is suitable for adults diagnosed with Type 2 diabetes who require combination therapy for better glucose control.
- Composition: Empagliflozin 25mg + Linagliptin 5mg
- Dosage Form: Oral Tablets
- Indication: Type 2 Diabetes Mellitus
- Mechanism: SGLT2 Inhibitor + DPP-4 Inhibitor
- Recommended Use: As prescribed by a healthcare professional
- Packaging: Standard pharmaceutical packaging
